Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted sulfonamides as selective .beta..sub.3 agonists for the treatment of diabetes and obesity

Substituted sulfonamides as selective .beta..sub.3 agonists for the treatment of diabetes and obesity

US Patent 5561142 · Granted Oct 1, 1996

Estimated economic value: $60,788,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AMPK activators2023
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the2017
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2015
Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes2015
Platelet-activating factor receptor antagonists2015
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2015
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2014
Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treat2014
Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment o2014
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2013